Funnel-web spider (Atrax robustus) antivenom. 1. Preparation and laboratory testing

Area of Science:

• Toxicology
• Pharmacology
• Veterinary Medicine

Background:

• The Sydney Funnel-web Spider (Atrax robustus) is highly venomous, posing a significant threat to humans.
• Envenomation by Atrax robustus can cause a severe autonomic crisis, leading to high morbidity and mortality.
• Effective antivenom therapy is crucial for managing Atrax robustus envenomation.

Purpose of the Study:

• To evaluate the efficacy of a rabbit-derived antivenom against Sydney Funnel-web Spider (Atrax robustus) envenomation.
• To assess the antivenom's ability to reverse the clinical syndrome caused by Atrax robustus venom.
• To determine the safety profile of the developed antivenom.

Main Methods:

• A rabbit-derived antivenom against Atrax robustus venom underwent rigorous quality control.
• The antivenom was administered to three monkeys following experimental envenomation.
• Clinical signs, particularly autonomic responses, were monitored in both conscious and anesthetized subjects.

Main Results:

• The antivenom successfully reversed the envenomation syndrome in all tested monkeys.
• A rapid attenuation of the autonomic crisis, a key factor in mortality, was observed.
• No adverse effects were associated with the administration of the antivenom.

Conclusions:

• The rabbit-derived Atrax robustus antivenom is effective in neutralizing the venom's effects.
• The antivenom rapidly alleviates the critical autonomic crisis associated with envenomation.
• The study supports the safety and efficacy of this new antivenom for potential clinical use.